Nucleic Acid Synthesis Inhibitors
DBCAT000593Pharmacologic class
Compounds that inhibit cell production of DNA or RNA. A DrugBank category of 70 drugs. 46 of them are approved.
- Also known as
- DNA Polymerase Inhibitors · DNA Synthesis Inhibitors · Inhibitors, DNA Polymerase · Inhibitors, DNA Synthesis · Inhibitors, Nucleic Acid Synthesis
- Drugs
- 5'-S-methyl-5'-thioadenosine
- Abacavir
- Acyclovir
- Adefovir
- Adefovir dipivoxil
- Ammonium trichlorotellurate
- Anisomycin
- Arsanilic acid
- Atevirdine
- Azacitidine
- Azathioprine
- Capecitabine
- Capravirine
- Cidofovir
- Clofarabine
- Cytarabine
- Dactinomycin
- Decitabine
- Delavirdine
- Dexelvucitabine
- Dichlororibofuranosylbenzimidazole
- Didanosine
- Echinomycin
- Efavirenz
- Elvucitabine
What you can answer from here — as of August 24, 2016
Which targets do Nucleic Acid Synthesis Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account